Lectin-specific targeting of lysosomal enzymes to reticuloendothelial cells - PubMed (original) (raw)
Lectin-specific targeting of lysosomal enzymes to reticuloendothelial cells
G J Murray. Methods Enzymol. 1987.
Abstract
The principles and methods used for enzymatic modification of the carbohydrate portion of glucocerebrosidase are similar to those performed by Ashwell and Morell, Stahl, and others. It is difficult to explain the lack of uptake of native enzyme through binding of the high-mannose type glycopeptide to Man/GlcNAc receptors since approximately 20% of the total oligosaccharides on the native enzyme are high mannose type. Possibly a requirement for multiple sites of attachment to the receptor is not met by a single high-mannose type oligosaccharide per molecule. Alternatively, the presence of complex type oligosaccharides on this enzyme, demonstrated by structural studies, may mask the mannose site and thus account for the poor uptake of native enzyme. The ability to successfully deglycosylate any protein or enzyme in order to specifically target a selected cell type requires that there be (1) an available source of pure enzyme; (2) specific exoglycosidases of high specific activity available either commercially or relatively easily purified; (3) chemical or biochemical means available for the testing of the product, preferably at each step; and (4) a means of separating the glycosidases used from the desired enzyme product. The characteristic and unique accumulation of glucocerebroside only in cells of the monocyte- histiocyte series, makes Gaucher's disease an excellent prototype for the study of enzyme replacement therapy. The principles demonstrated for the enzymatic deglycosylation of glucocerebrosidase may be applied to the cell-specific delivery of other glycoproteins as well. Other lysosomal diseases in which storage occurs in multiple cell types may be ameliorated by administration of macrophage-directed enzymes if, by so doing, storage material can be digested during the normal phagocytic turnover of senescent cells. Consideration of the kinetics of degradation and the structural features affecting the stability of enzymes in vivo are prerequisites to improving the bioengineering of targeted lysosomal enzymes. Animal and culture models have been developed for the study of glucocerebrosidase delivery to specific cell types and substrate degradation. Other studies have progressed toward a definition not only of the receptors at the plasma membrane involved in the internalization of exogenous enzyme, but also of internal receptors or properties of the lysosome responsible for intracellular protein trafficking. A complete understanding of the forces acting to direct endogenous or exogenously supplied enzyme to a given subcellular organelle will require a synthesis of experimental results from all areas of glycoprotein research.
Similar articles
- Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase.
Van Weely S, Aerts JM, Van Leeuwen MB, Heikoop JC, Donker-Koopman WE, Barranger JA, Tager JM, Schram AW. Van Weely S, et al. Eur J Biochem. 1990 Aug 17;191(3):669-77. doi: 10.1111/j.1432-1033.1990.tb19173.x. Eur J Biochem. 1990. PMID: 2143986 - Studies on the turnover of exogenous mannose-terminal glucocerebrosidase in rat liver lysosomes.
Murray GJ, Oliver KL, Jin FS, Brady RO. Murray GJ, et al. J Cell Biochem. 1995 Feb;57(2):208-17. doi: 10.1002/jcb.240570205. J Cell Biochem. 1995. PMID: 7759558 - Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation.
Furbish FS, Steer CJ, Krett NL, Barranger JA. Furbish FS, et al. Biochim Biophys Acta. 1981 Apr 3;673(4):425-34. doi: 10.1016/0304-4165(81)90474-8. Biochim Biophys Acta. 1981. PMID: 6784774 - A shortcut to the lysosome: the mannose-6-phosphate-independent pathway.
Coutinho MF, Prata MJ, Alves S. Coutinho MF, et al. Mol Genet Metab. 2012 Nov;107(3):257-66. doi: 10.1016/j.ymgme.2012.07.012. Epub 2012 Jul 20. Mol Genet Metab. 2012. PMID: 22884962 Review. - Lysosomal metabolism of glycoproteins.
Winchester B. Winchester B. Glycobiology. 2005 Jun;15(6):1R-15R. doi: 10.1093/glycob/cwi041. Epub 2005 Jan 12. Glycobiology. 2005. PMID: 15647514 Review.
Cited by
- Genetic disruption of multiple α1,2-mannosidases generates mammalian cells producing recombinant proteins with high-mannose-type _N_-glycans.
Jin ZC, Kitajima T, Dong W, Huang YF, Ren WW, Guan F, Chiba Y, Gao XD, Fujita M. Jin ZC, et al. J Biol Chem. 2018 Apr 13;293(15):5572-5584. doi: 10.1074/jbc.M117.813030. Epub 2018 Feb 23. J Biol Chem. 2018. PMID: 29475941 Free PMC article. - Current and Future Treatments for Lysosomal Storage Disorders.
Rastall DPW, Amalfitano A. Rastall DPW, et al. Curr Treat Options Neurol. 2017 Nov 4;19(12):45. doi: 10.1007/s11940-017-0481-2. Curr Treat Options Neurol. 2017. PMID: 29101575 Review. - Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.
Solomon M, Muro S. Solomon M, et al. Adv Drug Deliv Rev. 2017 Sep 1;118:109-134. doi: 10.1016/j.addr.2017.05.004. Epub 2017 May 11. Adv Drug Deliv Rev. 2017. PMID: 28502768 Free PMC article. Review. - Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.
Muro S. Muro S. Drug Deliv Transl Res. 2012 Jun 1;2(3):169-86. doi: 10.1007/s13346-012-0072-4. Drug Deliv Transl Res. 2012. PMID: 24688886 Free PMC article. - Imiglucerase in the treatment of Gaucher disease: a history and perspective.
Deegan PB, Cox TM. Deegan PB, et al. Drug Des Devel Ther. 2012;6:81-106. doi: 10.2147/DDDT.S14395. Epub 2012 Apr 18. Drug Des Devel Ther. 2012. PMID: 22563238 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous